ImmunoBiome

Microbiome-targeted therapeutics for intractable immune diseases

ImmunoBiome is headquartered in Pohang, South Korea, lists 1–10 employees, and has 2 recorded funding rounds.

Headquarters
Pohang
Employees
1–10
Business Model
B2B
Last Round
SeedDec 2019
Rounds
2

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

ImmunoBiome Inc. is a South Korean biotech company located within the POSTECH (Pohang University of Science and Technology) campus, focused on developing microbiome-based therapeutics for intractable immune diseases including cancer and autoimmune conditions. The company leverages advanced immunology, bioinformatics, and microbiome-oriented basic research to discover and develop novel live biotherapeutic products. Its lead pipeline candidates IMB001 and IMB002 target oncology and inflammatory disease indications.

Summary

ImmunoBiome is a Biotech company based in Pohang, South Korea. It lists 1–10 employees. Its most recent funding was a Seed round in Dec 2019. Investors include SBI Investment Korea, Union Ventures and AJU IB Investment.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2019

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ImmunoBiome on Indexed.vc
<a href="https://indexed.vc/companies/immunobiome"><img src="https://indexed.vc/api/badge/company/immunobiome" alt="ImmunoBiome on Indexed.vc" width="260" height="76" /></a>